Skip to main content

Press Release: Standard Textile Announces Sponsorship of the Launch of the 2019 International Pressure Ulcer/Injury Prevention and Treatment Clinical Practice Guideline (CPG)

The CPG is a consolidation of current evidence-based clinical practice recommendations from around the world for the prevention and treatment of pressure injuries.

CINCINNATI, Ohio (November 15, 2019) – Standard Textile announces its supporting sponsorship of the National Pressure Injury Advisory Panel’s (NPIAP) launch of the 2019 International Pressure Ulcer/Injury Prevention and Treatment Clinical Practice Guideline (CPG) on Friday, November 15-16, 2019 at the University of Southern California (USC) Campus in Los Angeles, Calif.

To create the 2019 International Guideline:

  • Over 1,200 consumers from around the world completed surveys that identified their concerns and goals for pressure injury prevention and treatment.
  • Fourteen international associate organizations partnered in the guideline development process.
  • More than 3,500 research studies were reviewed to answer key clinical questions.

Silk-like fabric has been recognized and recommended in the NPIAP’s most recent Clinical Practice Guideline: “Consider using silk-like fabrics rather than cotton or cotton-blend fabrics to reduce shear and friction.”

DermaTherapy® by Standard Textile is the first and only silk-like therapeutic linen system with FDA 510(k)2, 3 clearance as a Class I medical device to reduce the likelihood of patients developing pressure injuries.

For information, visit DermaTherapy.StandardTextile.com.

To read more from this press release, click here.

2 FDA 510(K) Clearance No. K152884. Indications for Use: Bed linens made with DermaTherapy® fabrics are intended for use by patients 18 years of age and older in hospital settings who are susceptible to pressure ulcers. The DermaTherapy® Bed Linens help to reduce the likelihood of patients developing pressure ulcers by reducing moisture, friction and shear on the patient’s skin.

3 FDA 510(K) Clearance No. K061242. Indications for Use: Institutional Bedding (bed sheets and pillow cases) made with DermaTherapy® fabrics is intended for use by patients in a hospital, healthcare or home setting who are susceptible to or may have mild atopic dermatitis.

DermaTherapy® was developed in partnership between Standard Textile Co., Inc. and Precision Fabrics Group. DermaTherapy® is a registered trademark of Precision Fabrics Group, Inc.

Contact:
Judy Sroufe
Vice President, Brand Marketing and Communications, Standard Textile
jsroufe@standardtextile.com
(513) 761-9256

Back to Top